CD4 and neoplasm: We further investigated the effect of ADCC enhancement of BAT6026 on the proportions of CD4+ T cells and Tregs in mouse tumor, and the results showed that these cells were significantly reduced in mice treated with BAT6026 compared to its cognate antibody with regular ADCC, BAT6026-wt.